Contrasting Clozapine Prescribing Patterns in the East and West ?

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 1, 2000, Pages 75-78

  Chong, Siow Ann ^b   Remington, G J ^a   Lee, N ^c   Mahendran, R ^c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b INSTITUTE OF MENTAL HEALTH   (Singapore)

^c NONE

Author keywords

Clozapine; East; Polypharmacy; West

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CANADA; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PSYCHIATRIC TREATMENT; PSYCHIATRIST; SCHIZOPHRENIA; SINGAPORE;

EID: 0034118872     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kane J M. Management and strategies for the treatment of schizophrenia. J Clin Psychiatry 1999; 60 (suppl 12):13-7.
2. Hegarty J D, Baldessarini R J, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994; 15:1409-16.
3. Hippus H. A historical perspective of clozapine. J Clin Psychiatry; 60 (suppl 12):22-3.
4. Kane J, Honigfled G, Singer J, Meltzer H, and the Clozaril Collaborative Study Group. Clozapine for the treatment-resistent schizophrenic. Arch Gen Psychiatry 1988; 45:789-96.
5. Kane J. Clinical efficacy of clozapine in treatment of refractory schizophrenia: an overview. Br J Psychiatry 1992; 18(suppl 17):41-54.
6. Fleischhacker W W, Hummer M, Kurz M, Kurthaler I, Lieberman J A, Pollack S, et al. Clozapine dose in the United States and Europe: implications for therapeutic and adverse effects. J Clin Psychiatry 1994; 55(Suppl9):78-81.
7. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Schizophrenia. Washington DC: American Psychiatric Association, 1997.
8. Szymanski S, Lieberman J, Pollack S, Kane J M, Safferman A, Munne R, et al. Gender differences in neuroleptic on responsive clozapine-treated schizophrenics. Biol Psychiatry 1996; 39:249-54.
9. Jann M W, Liu H C, Wei F C, Lin S K, Lin S K, Hu W H, et al. Gender differences in plasma clozapine levels and its metabolites in schizophrenic patients. Hum Psychopharmacol 1997; 12:489-95.
10. Chong S A, Remington G. Ethnicity and clozapine metabolsim. Br J Psychiatry 1998; 172:97.
11. Naber D, Holzbach R, Perro C, Hippus H. Clinical management of clozapine patients in relation to efficacy and side effects. Br J Psychiatry 1992; 160 (suppl 17):54-9.
12. Peacock L, Gerlach J. Clozapine treatment in Denmark: concomitant psychotropic medication and hematologic monitoring in system with liberal usage practices. J Clin Psychiatry 1994; 55:44-9.
13. Potter W Z, Ko G N, Zhang L D, Yan W. Clozapine in China: a review and preview of US/PRC collaboration. Psychopharmacology 1989; 99: S87-S97.
14. Mowerman S, Siris S G. Adjunctive loxapine in a clozapine-resistant cohort of schizophrenic patients. Ann Clin Psychiatry 1996; 8:193-7.
15. Faisal I, Lindenmayer J P, Taintor Z, Cancro R. Clozapine-benzodiazepine interactions. J Clin Psychiatry 1997; 58:574-8.
16. Frankenburg, F, Baldessarini R J. Clozapine - a novel antipsychotic. N Engl J Med 1991; 325: 51.
17. Nunley M. Why psychiatrists in India prescribe so many drugs. Cult Med Psychiatry 1996; 20:165-97.
18. Binder R L, Kazamatsuri H, Nishimura T, McNiel D E. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan. Am J Psychiatry 1987; 144:1494-6.
19. Philips M R, Lu S H, Wang R W, Wang R W. Economic reforms and the acute inpatient care of patients with schizophrenia: The Chinese experience. Am J Psychiatry 1997; 154:1228-34.